FOLH1 and neoplasm: Nonetheless, overall small molecule PSMA ligands, such as PSMA-N064 extravasate quickly, have a better tumor penetration, clear more rapidly from the blood, and show higher tumor-to-background ratios compared to antibodies [15, 25].